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Abstract 
Objectives To examine the efficacy and feasibility of an online prerace medical screening and 
educational intervention programme for reducing medical complications in long-distance races. 
Methods This was an 8-year observational study of medical encounter rates among 153 208 Two 
Oceans race starters (21.1 and 56 km) in South Africa. After the first 4-year control (CON) period, we 
introduced an online prerace medical screening (based on European pre-exercise screening guidelines) 
and an automated educational intervention programme. We compared the incidence of medical 
encounters (per 1000 starters; all and serious life threatening) in the CON versus the 4-year intervention 
(INT) period. 
Results In comparison to the CON period (2008–2011: 65 865 starters), the INT period (2012–
2015: 87 343 starters) had a significantly lower incidence (adjusted for age group, sex, race distance) of 
all medical encounters by 29% (CON=8.6 (7.9–9.4); INT=6.1 (5.6–6.7), p<0.0001), in the 21.1 km 
race by 19% (CON=5.1 (4.4–5.9); INT=4.1 (3.6–4.8), p=0.0356) and in the 56 km race by 39% 
(CON=14.6 (13.1–16.3); INT=9.0 (7.9–10.1), p<0.0001). Serious life-threatening encounters were 
significantly reduced by 64% (CON=0.6 (0.5–0.9); INT=0.2 (0.1–0.4); p=0.0003) (adjusted for age 
group and sex). Registration numbers increased in the INT period (CON=81 345; INT=106 743) and 
overall % race starters were similar in the CON versus INT period. Wet-bulb globe temperature was 
similar in the CON and INT periods. 
Conclusion All medical encounters and serious life-threatening encounters were significantly lower 















Regular physical activity (PA) is an important lifestyle intervention for primary and 
secondary prevention of non-communicable disease.1–5 The recommended minimum weekly 
healthy ‘dose’ of exercise is 150 min at moderate to vigorous intensity.5–7 Mass community-
based sports events such as distance running events have, over the last two to three decades, seen 
substantial growth in participant numbers,8 with a notable increase in older participants 
(http://www.runningusa.org/annual-reports). While regular PA has numerous health benefits, PA is 
associated with medical encounters,9 10 including acute myocardial infarction and sudden 
death.11–16 
 
The reported absolute risk of sudden death during marathons, and similar races, varies between 
0.004 and 0.033 per 1000 race entrants.17–23 The incidence of other non-cardiac, but serious 
life-threatening medical encounters during running is not well studied,22–28 but is about 0.5 
per 1000 race entrants (0.17–1.55 per 1000 race entrants).22 23 28 To reduce the risk of acute 
medical complications during sport, precompetition medical evaluation has been proposed, with 
the main focus on younger elite athletes.14 29–33 However, the older exercising population has a 
higher incidence of acute medical complications during exercise34 and a number of 
international organisations developed consensus recommendations for preparticipation 
screening of master athletes35–37 or middle-aged/senior individuals wishing to engage in leisure 
time sports (European Association for Cardiovascular Prevention and Rehabilitation, EACPR).29 
We recently reported that using the EACPR guidelines, >30% runners would require a full medical 
assessment before race participation—mainly linked to runners reporting musculoskeletal 
conditions. We therefore suggested a revision of these guidelines and proposed that prerace 
screening be considered to identify runners with a ‘very high’, ‘high’ and ‘intermediate risk’ for 
medical complications during exercise.38 We are not aware of any studies investigating the 
efficacy of preparticipation medical screening to reduce acute medical encounters in athletes 
who engage in leisure time sports such as mass community-based distance running events. 
 
Therefore, the primary aim of this study was to determine the efficacy of an online preparticipation 
screening and educational intervention programme to reduce the incidence of acute medical 
encounters, including serious life-threatening encounters and deaths, at distance running events. 
Secondary aims were to: (A) explore whether the screening and intervention strategy could be 
easily or conveniently performed (feasibility); (B) examine if extrinsic factors such as 
environmental stress could account for variation in medical encounters rather than the 
prescreening; and (C) determine if the intervention programme altered the race entrant risk 
profile. 
 
Methods study design 
We conducted an observational study over 8 years with a 4-year initial control (CON) period 





Participants and data collection 
The Two Oceans Marathon races are mass community-based running events in South Africa 
and comprise a 21.1 km and a 56 km race. Entries to the 21.1 km race are open to novice 
runners and require no qualifying time, while entry for the 56 km race requires a sub-5-hour 42.2 
km-qualifying time. Entrants, defined as any runner registering for the races (typically open 3–5 
months before the races), for both races over an 8-year period (2008–2015) were considered 
as participants. In each of the 8 years of the study (control and intervention) race entrant data 
(demographics including age, sex, previous participation and previously completed races) and 
race day data (number of starters and finishers) were obtained, with permission, from the race 
organisers. Demographic and race data are in the public domain and are obtainable from the race 
website. 
 
In each year of the study (CON and INT periods), we obtained the deidentified data on medical 
encounters in runners who presented to the medical facilities on race day, with permission, from 
the race medical team and the race organisers. Medical facilities consisted of on-route medical 
stations and a medical facility at the finish. For the purposes of this study, a medical encounter 
was defined as ‘any runner who required medical care on race day that was severe enough 
to warrant a medical assessment by a doctor, either in the medical facility at the end of 
the race, on route at the medical stations, or at one of the referral hospitals (for runners 
that were assessed by medical staff on the route)’. Minor medical encounters (not requiring an 
assessment by a medical doctor) were not included in our study. A serious life-threatening 
medical encounter was defined as ‘a medical encounter that could result in death unless 
urgently diagnosed and treated, specifically encounters that resulted in either admission 
to a high-care (intensive care and observation) medical area at the event, or transport (with 
or without admission) to a hospital’. An event-related sudden death was defined as ‘a medical 
encounter that resulted in sudden death, where the medical problem resulting in death was 
deemed to be directly related to the event, and the onset of the medical problem occurred 
during the event or within 24 hours of the finish time’. Race physicians recorded accurate 
and detailed clinical information of each medical encounter in a standardised format. 
 
InT period: online prerace medical screening, risk stratification and 
educational intervention 
In the INT period (2012–2015), we introduced a compulsory online prerace medical screening 
questionnaire or ‘self-assessment of risk’ based on the EACPR guidelines.29 39 The 
questionnaire consisted of the following main categories of medical history: cardiovascular 
disease (CVD), symptoms of CVD, risk factors for CVD, other chronic disease (respiratory 
disease, metabolic or hormonal disease, gastrointestinal disease, nervous system disease, renal or 
bladder disease, haematological or immune system disease, cancer, allergies), general 
prescription medication use, medication use during racing and a history of collapse during 
racing (online supplementary table S1). Algorithms were developed to risk stratify runners into 
one of four risk categories (online supplementary table S2), based on the EACPR guidelines.29 




automated fashion and runners completing the screening were given the opportunity to consent 
that their data could be used for research purposes. 
 
Educational intervention programme 
In conjunction with the online prerace medical screening questionnaire, an educational 
intervention programme was developed to educate runners, via automated email, on the potential 
medical complications that may occur during moderate to high-intensity exercise (online 
supplementary table S3). Educational material was delivered to runners in the two highest risk 
categories (‘very high risk’ and ‘high risk’) by personalised email and they were specifically 
advised to seek clearance from their medical practitioner. In addition, we conducted a general 
educational intervention to all runners through weekly posts on a dedicated medical section of 
the official race website, and regular email notification to all runners to visit the race website. No 
runner was prevented from race participation by the race organisers or the race medical team. 
The final decision to run on race day was left to the runner and his/her medical practitioner. 
 
Primary outcome measures to assess efficacy 
Incidence of race day medical encounters 
The incidence of all medical encounters, serious life-threatening medical encounters and deaths was 
the main outcome measure to assess efficacy of the intervention. The incidence was calculated as the 
number of runners with medical encounters or deaths per 1000 race starters. The main analysis was 
by observation period (control: 2008–2011; intervention: 2012–2015), with further analysis of 
the incidence in subgroups by race distance (21.1 km or 56 km race). 
 
Secondary outcome measures 
Race entrant numbers, did-not-start rate and did-not-finish rate For the purposes of this study, we 
used additional main outcomes to address possible concerns of race organisers that the screening and 
intervention programme may reduce race entry numbers, or increase dropout after race entry by 
reducing the number of race starters: 
► The number of race entrants was defined as the number of runners registered for the races 
(typically 3–5 months before the races). The rationale for this outcome measure is that race 
organisers may express a possible concern that by implementing the intervention, it may 
negatively affect race entries. 
► Race starters were defined as race entrants who started the race and we report the did-not-start 
(DNS) rate (% entrants who did not start the race). The runners who started, but did not finish 
the race, is reported as did-not-finish (DNF) rate (%). The rationale for these outcome 
measures is to address a potential concern that the intervention may result in a greater % race 
entrants not starting or finishing the race. 
 
Influence of environmental stress on medical encounter rates 
We collected data on environmental conditions (hourly from 06:00 to 12:00) on race day of 
each year (temperature, humidity, rainfall, cloud cover and wind speed) from the database of the 
South African Weather Services (with permission). We used the wet-bulb globe temperature 
(WBGT) Index (calculated using WBGT (°C), humidity, time of day and cloud cover data) as the 





Risk profile of race starters changed in the intervention 
In the INT period, 87 343 runners started the race, and 76 654 runners (87.8% of starters) gave 
consent that their medical information (risk category data) could be used for research purposes. 
Data on the % race starters in each risk category (online supplementary table S3) were only 
available in the INT period. The DNS in the INT period was used as an outcome variable to 
determine if the risk profile of race starters changed in the 4-year INT period. 
 
Statistical analysis of data 
All analyses were done using the SAS (V.9.4) statistical analysis system. Modified Poisson 
regression models using a robust error estimator (log link function) to estimate the incidence 
rates (IR) and CIs were used to analyse all medical outcomes. The correlated structure of the 
data, due to the same athletes taking part in several of the races over the 8-year study period, was 
accounted for by using an unstructured correlation matrix. Data are provided to show the number 
of unique athletes in the CON and INT periods. The estimate of the prevalence risk and 95% CI 
for the CON and INT periods were reported and the estimated relative risk (RR) was reported 
as a measure of the intervention effect. Models compared outcomes CON and INT, reporting 
prevalence risks and 95% CIs. 
 
Models for any medical encounters included the individual years, and contrasted CON (2008–
2011) versus INT (2012– 2015) years to obtain RRs and 95% CIs. Models for serious life-
threatening/death medical encounters included an indicator for CON and INT to obtain RRs and 
95% CIs. 
 
Unadjusted model results for medical encounters are reported in the online supplementary 
appendix. Adjusted models included possible confounders of race distance, sex and age category 
to adjust the intervention estimates. The interaction term for race distance and year was included 
to obtain separate estimates for the two race distances. 
 
The possible influence of environmental stress on the association between medical 
encounters and the intervention was assessed by including wind speed and WBGT index as a 
confounder in the final model. 
 
For the comparison of risk categories for chronic illness, the ‘very high risk’ and ‘high risk’ 
categories were combined and the ‘intermediate risk’ and ‘low risk’ categories were combined in a 
model that was adjusted for age category, sex and race distance. 
 
Results 
Study population and overall race starter demographics 
Over the 8-year study period, a total of 87 525 unique runners were studied: 26 753 runners 
who only took part in the CON period, 38 719 who only took part in the INT period and 22 
053 runners who took part in both periods. In the 8-year study period, there were 188 088 race 
entrants and 153 208 race starters (81.5%). Demographic details of all race starters in the CON 




CON and INT periods included 92 038 male starters (CON=41 026; INT=51 012) and 61 170 
female starters (CON=24 839; INT=36 331). 
 
Incidence of medical encounters (COn vs InT period) 
All medical encounters 
The unadjusted (crude) incidence of all medical encounters is available in the online 
supplementary table S5. The adjusted (age category, sex) incidence (per 1000 race starters) 
of all medical encounters in all runners (p<0.0001), 21.1 km runners (p=0.0356) and 56 km 
runners (p<0.0001) was significantly lower in the INT period—a 29% reduction in all runners, 
and a 19% and 39% reduction in the 21.1 and 56 km runners, respectively (table 1). 
 
The number needed to treat (NNT) statistic of the screening and educational intervention to 
prevent one medical encounter is 394 for all runners, 1053 for 21.1 km runners and 177 for 






Serious life-threatening (including death) medical encounters 
There were only 39 and 19 serious life-threatening (including death) medical encounters, 




2015 were combined for the analysis. The unadjusted (crude) incidences of serious life-
threatening (including death) medical encounters are available in the online supplementary table S6. 
 
In the adjusted analysis (for age category and sex) incidence of serious life-threatening medical 
encounter, data were analysed for the two race distances separately and combined. In the INT 
period, the adjusted incidence (per 1000 runners; 95% CI) of serious life-threatening (including 
death) medical encounters was reduced significantly in all runners (p=0.0003) and 21.1 km 
runners (p=0.0014) (table 2). 
 
In 56 km runners, there was a trend for a reduction in serious life-threatening (including 
death) medical encounters (p=0.0666). In total, in the INT period, there was 64% reduction in 
the risk of a serious life-threatening (including death) medical encounter in all runners, with a 
74% and 52% reduction in the risk for 21.1 and 56 km runners, respectively. 
 
The NNT statistic of the screening and educational intervention to prevent one serious (life-
threatening/death) medical event was 2670 (for all runners) (unadjusted data). 
 
Race entrants, DNS rate and DNF rate 
The number of race entrants, race starters and finishers, and the percentage (%) of race entrants 
that did not start the race or did not finish the race in the CON versus INT period are shown in 
table 3. The number of race entrants increased by 31% from the CON to the INT period. DNS and 
DNF rates were similar in the pre-INT and post-INT periods. 
 
Environmental stress and medical encounter rates 
The environmental conditions on race day for each year and in the CON and INT periods are 
shown in table 4. 
 
The means of the calculated WBGT index over the 8-year period ranged from a minimum of 
12.1 to 18.4. There was no significant difference in the WBGT index between the CON and the 
INT period (p=0.5289). The average wind direction (degrees) was not significantly different in 
the INT period versus CON period (p=0.1431). However, the average wind speed (knots) was 
significantly higher in the INT period versus CON period (p<0.0001). There was no correlation 
between either WBGT index (p=0.4927) or wind speed (p=0.7558) and the incidence of all 
medical encounters over the 8-year study period (online supplementary figure S1). 
 
Finally, the effect of environmental stress on the association between medical encounters and 
the intervention was also assessed by including wind speed and WBGT index as a confounder 
in the final model on IRs of all medical encounters. This adjustment of the intervention effect 
for environmental stress resulted in no significant change to the RR (0.75; 95% CI 0.62 to 0.91) 








Race starter risk profile in the InT period 
The observed number and % race starters in the INT period (consenting race starters; n=76 654) 
in each risk category (determined by chronic illness and risk factors for chronic illness), by year 
and race distance in the post-INT period, are depicted in table 5. 
 
The percentage of ‘very high-risk’ and ‘high-risk’ race starters in the 4-year INT period was 3.1% 
and 11.0%, respectively, and these were similar in the 21.1 and 56 km runners (table 5). There was a 
significant decrease in the combined percentage of ‘very high-risk’ and ‘high-risk’ race starters in 
over the 4-year period (2012=16.8%;   2013=14.0%;   2014=13.4%;   2015=12.8%) (p<0.0001) 
(adjusted for age category, sex and race distance). 
 
Discussion 
It is well established that the risk of a medical encounter (including sudden death) during 
prolonged moderate to high-intensity exercise is related to extrinsic factors (environmental 
stress,40–42 race distance23) and intrinsic factors (older age,8 13 43 men8 13). Underlying 
chronic disease and risk factors for chronic disease are recognised as risk factors associated with 
medical complications during moderate to high-intensity exercise. Therefore, international medical 
associations have produced consensus-based recommendations/guidelines to screen individuals 
prior to engaging in moderate to high-intensity exercise.29 35–37 39 To our knowledge, this is the 
first study investigating the efficacy of a prerace medical screening and educational intervention 
programme to reduce the incidence of all medical encounters in recreational distance runners 
participating in a mass community-based sports event. In only one other recent study, a prerace 
educational intervention programme was implemented to reduce the risk of exercise-associated 
collapse in runners.44 Our main finding is that a prerace screening and educational intervention 
was associated with a significant reduction in medical encounters (by 29%), particularly serious life-
threatening medical encounters (by 64%). We also show that our observed reductions in 
medical encounter rates could not be accounted for by known risk factors for medical encounters 
such as age, sex, race distance and environmental conditions. We also present some data that our 
intervention programme did not negatively affect overall number of race entrants. 
 
In 2008, we initiated studies to reduce the risk of an adverse medical event during exercise: the 
SAFER (Strategies to Reduce Adverse Medical Events for the Exerciser) studies.23 45–47 
In the first of these studies, we recorded a high incidence of sudden cardiac death and other 









We concluded that it should be a priority to reduce these medical encounters. Therefore, from 
2012, we introduced prerace medical screening, as proposed by the EACPR,29 with an 
educational intervention programme at running events. As far as we are aware, this observational 
study, with a 4-year CON and a 4-year INT period, is the first to show promising results that a 
prerace medical screening and educational intervention can reduce acute medical encounters in 
master and leisure athletes who participate in mass community-based distance running events. 
 
In this study, we carefully considered other risk factors that may account for variations in medical 
encounter rates, including age, sex, race distance and environmental stress. We adjusted all IRs 
for age and sex, and report data separately for the two race distances (21.1 and 56 km). We show 
that the incidence of medical encounters was highest in the longer 56 km race, and this is 
consistent with previous findings.23 However, we also show that the incidence of medical 
encounters in the INT period was significantly reduced in both races, particularly serious life-
threatening medical encounters. 
 
We are aware that environmental stress (specifically the WBGT) has been associated with increased risk 
of medical encounters at endurance sports events,40 41 and there are international guidelines for 




considered whether environmental stress (specifically the WBGT index) could account for our 
observed reduction in medical encounters in the INT period. Our results show that the WBGT over 
the 8-year period was not related to the incidence of medical encounters, and we attribute this 
observation to two main factors: the relatively small variation in the WBGT index over the 8-year 
study period, and that WBGT values were consistently in the ‘low to moderate’ risk for the entire 8-
year period.40 We note that the highest WBGT value was recorded in the INT period (2013). Our 
data therefore show that environmental conditions did not account for our observed reduction in 
medical encounters following the intervention. 
 
We also recognised that the feasibility of implementing preparticipation medical screening is a 
key aspect for potential wider application. It should be simple, pragmatic, not introduce 
barriers to participation and not be counterproductive to the public health message of the 
benefits of regular exercise. A potential threat, largely expressed by race organisers, is that a 
prerace screening programme would negatively affect race entry numbers and/or result in fewer 
entrants starting the race. Other concerns could be that runners would have a negative attitude 
towards the prerace screening process, and that the cost to a healthcare system would increase 
significantly. 
 
Our results show that the number of race entrants was not reduced in the post-INT period; 
rather, there was a 31% growth in race entrants. The percentage of overall entrants not starting the 
race was similar in the CON and INT periods. Most runners (>70%) gave consent that their 
prerace medical data could be used for research, and the % consenting runners increased over the 
4–year period from 62% in 2012 to 78.4% in 2015, perhaps indicating that runners did not view 
the screening and education negatively. We believe the data indicate that prerace medical screening 
and education did not negatively impact race participation, and the majority of the runners support 
research endeavours to improve race safety. 
 
We did not specifically study the potential cost implication of runners who were advised to 
undergo medical clearance before participation. However, only about 14% of race entrants 
were in the two higher risk categories, and we advised them to seek medical clearance. Most of 
these runners are under the care of medical practitioners, and undergo routine medical 







Our educational intervention encouraged these runners to discuss the medical 
considerations when participating in endurance running events with their physician. We 
suggest that, for these runners, this should not add a cost burden to the healthcare system. 
The exception would be a small number of runners who reported only symptoms suggestive 
of CVD. This would result in a new consultation with a medical practitioner, and be an 
additional cost to the healthcare system. However, this has to be balanced with the cost 
saving associated with any reduction in medical encounters during exercise. 
 
We do not have any data on the risk profile (chronic illness and risk factors for chronic 
illness) of race entrants in the 4-year CON period. These data have never been reported, and 
we could not obtain these data without informing race entrants of increased risk of a medical 
complication during exercise, as this would have important ethical implications. However, we 
could study the effects of the intervention programme on altering the risk profile of race 
starters, but only in the 4-year INT period. We were encouraged by the observation that there 
was a significant reduction in the % ‘very high-risk’ or ‘high-risk’ race starters over the 4-year 
intervention, and we note that the largest reduction was after the first year in the INT period. 
 
The strengths of this study are the large number of runners studied over an 8-year period, the 
accurate and consistent documentation of the medical encounters, that we adjusted medical 
encounter rates for risk factors such as age, sex and race distance, and that we show that 
environmental stress, specifically WBGT index, did not account for our observed reduction 
in medical encounters. This study has several limitations. First, this was not a randomised 
controlled trial, but rather a pragmatic field study, and we therefore cannot conclude that the 
reduction in the incidence of medical encounters was only as a result of our intervention. 
Second, we acknowledge that the intervention consisted of multiple components including 
screening and risk stratification, combined with an individually targeted educational 
intervention for ‘very high-risk’ and ‘high-risk’ subgroups and a general educational 
intervention for all runners. Therefore, any effect of our intervention cannot be attributed 
to a single component of the intervention. Third, we relied on self-reported data from 
runners. Fourth, we  acknowledge that we do not have data on the individual runner risk 
profile (chronic illness and risk factors) in the CON period and therefore we cannot show that 




report any data to show that runners complied with the advice to seek medical clearance, but 
we did collect information on how many runners sought medical clearance in the period 
2013–2015. Larger studies, including more endurance events and thus more serious medical 
encounters, are needed to confirm the results of the present study. 
 
In summary, our study shows promising results that following the introduction of an online 
prerace medical screening and educational intervention programme at a mass community-
based running event, we observed a reduction in all medical encounters, mainly in longer 
races, and serious life-threatening medical encounters, mainly in the shorter race. In addition, 
the screening and intervention programme was easily accomplished, and appears to alter the 
race starter risk profile. Therefore, a prerace screening and educational intervention has the 
potential to change current practice worldwide and we suggest that race organisers and race 
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